Free Trial

DOWLING & PARTN Has Negative View of MetLife FY2026 Earnings

MetLife logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • DOWLING & PARTN slightly cut its FY2026 EPS forecast for MetLife to $10.25 from $10.30, but that remains above the $9.91 analyst consensus.
  • MetLife’s latest quarter modestly beat expectations, with EPS of $2.78 versus $2.77 forecast and revenue of $20.52 billion, up 18.2% year over year.
  • Analyst sentiment is broadly positive: 14 analysts rate the stock Buy and one Hold, with a consensus price target of $107.12; MetLife also has a $3 billion share-repurchase authorization and a 2.3% dividend yield.
  • Five stocks we like better than MetLife.

MetLife, Inc. (NYSE:MET - Free Report) - Analysts at DOWLING & PARTN dropped their FY2026 earnings per share estimates for shares of MetLife in a research note issued to investors on Tuesday, November 10th. DOWLING & PARTN analyst J. Hurwitz now expects that the financial services provider will post earnings per share of $10.25 for the year, down from their prior forecast of $10.30. The consensus estimate for MetLife's current full-year earnings is $9.91 per share.

Several other research firms have also weighed in on MET. Wall Street Zen raised MetLife from a "hold" rating to a "buy" rating in a research report on Sunday. Jefferies Financial Group raised their price objective on MetLife from $103.00 to $115.00 and gave the stock a "buy" rating in a research report on Monday, August 10th. Argus lifted their target price on MetLife from $93.00 to $109.00 and gave the company a "buy" rating in a research note on Wednesday, September 2nd. Barclays upped their target price on MetLife from $97.00 to $111.00 and gave the company an "overweight" rating in a report on Wednesday, October 7th. Finally, Evercore reissued a "mixed" rating on shares of MetLife in a research report on Monday, August 24th. Fourteen equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $107.12.

Check Out Our Latest Report on MET

MetLife Price Performance

MET opened at $102.67 on Monday. MetLife has a 12-month low of $67.33 and a 12-month high of $106.72. The company has a quick ratio of 0.21, a current ratio of 0.21 and a debt-to-equity ratio of 0.65. The firm has a market capitalization of $64.52 billion, a P/E ratio of 13.39, a PEG ratio of 0.97 and a beta of 0.79. The stock has a fifty day moving average of $98.75 and a 200-day moving average of $86.90.

MetLife (NYSE:MET - Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The financial services provider reported $2.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.77 by $0.01. The firm had revenue of $20.52 billion for the quarter, compared to the consensus estimate of $19.86 billion. MetLife had a return on equity of 25.71% and a net margin of 6.21%. The business's revenue for the quarter was up 18.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.34 EPS.

MetLife Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 8th. Stockholders of record on Tuesday, November 3rd will be paid a $0.5925 dividend. The ex-dividend date of this dividend is Tuesday, November 3rd. This represents a $2.37 dividend on an annualized basis and a dividend yield of 2.3%. MetLife's dividend payout ratio is 30.90%.

MetLife declared that its Board of Directors has authorized a stock repurchase plan on Wednesday, August 5th that allows the company to buy back $3 billion in outstanding shares. This buyback authorization allows the financial services provider to reacquire up to 4.8% of its shares through open market purchases. Share buyback plans are generally a sign that the company's management believes its shares are undervalued.

Insider Activity

In related news, CEO Michel Khalaf sold 187,425 shares of the stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $102.97, for a total transaction of $19,299,152.25. Following the completion of the sale, the chief executive officer directly owned 759,013 shares in the company, valued at approximately $78,155,568.61. This trade represents a 19.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.40% of the company's stock.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Jump Financial LLC raised its stake in shares of MetLife by 46.2% during the 3rd quarter. Jump Financial LLC now owns 12,708 shares of the financial services provider's stock worth $1,197,000 after purchasing an additional 4,017 shares in the last quarter. Flputnam Investment Management Co. grew its stake in shares of MetLife by 7.0% in the 3rd quarter. Flputnam Investment Management Co. now owns 5,882 shares of the financial services provider's stock valued at $554,000 after buying an additional 383 shares in the last quarter. FORA Capital LLC grew its stake in shares of MetLife by 106.2% in the 3rd quarter. FORA Capital LLC now owns 92,822 shares of the financial services provider's stock valued at $8,741,000 after buying an additional 47,809 shares in the last quarter. Pathstone Holdings LLC grew its stake in shares of MetLife by 13.0% in the 3rd quarter. Pathstone Holdings LLC now owns 126,979 shares of the financial services provider's stock valued at $11,956,000 after buying an additional 14,641 shares in the last quarter. Finally, Cornermen Financial LLC acquired a new position in MetLife in the third quarter worth approximately $470,000. 94.99% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting MetLife

Investors following MET have been watching these headlines:

  • Positive Sentiment: Analysts raised their price targets. Mizuho lifted its target to $117 from $112 and maintained an “outperform” rating; Wells Fargo raised its target to $113 from $110 and kept an “overweight” rating. The higher targets indicate continued analyst confidence and potential upside. Mizuho price target article Wells Fargo price target article
  • Neutral Sentiment: MetLife earned workplace recognition. The company was named among the 2026 Fortune World’s Best Workplaces and topped U.S.-based financial services and insurance companies on the list. This may support its reputation as an employer, though the direct impact on near-term earnings is unclear. Fortune workplace ranking article
  • Negative Sentiment: CEO Michel Khalaf sold 187,425 shares for about $19.3 million, reducing his position by 19.8%. Insider sales can concern investors, although Khalaf retained 759,013 shares after the transaction. CEO share sale article

MetLife Company Profile

(Get Free Report)

MetLife, Inc. is a global financial services company best known for providing insurance, employee benefits and retirement-related products. Its offerings include life, dental and disability insurance, annuities, and products and services designed to help individuals and employers plan for financial protection and retirement. The company serves individuals, businesses and institutions in the United States and international markets, including countries in Latin America, Asia, Europe and the Middle East.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in MetLife Right Now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines